Literature DB >> 15799763

Cross-reactivity between human adenoviruses in delayed-type hypersensitivity.

Marta Bakay1, Katalin Szalay, Ilona Beladi, Elisabeth Balint, Anna Lengyel, Eva Adam, Tibor Olah.   

Abstract

The aim of this study was to determine the antigen responsible for the induction of delayed-type hypersensitivity (DTH) by human adenoviruses (Ads). The estimation of DTH was based on measurement of the extent of swelling of the hind footpads of mice. CsCl density gradient-purified human Ad serotype 6 (Ad6) induced DTH in a dose-dependent manner. In Ad6-sensitized mice, DTH could be elicited by serotypes belonging to the same species of human Ads (types 1 and 5) and by a serotype (type 3) belonging to another species. Latex particles coated with purified hexon antigen prepared from Ad5 had the capacity to sensitize mice and elicit a DTH reaction. We suggest that, for serotypes belonging to species C, the cross-reactive highly conserved T cell epitope of the hexon protein might be responsible for the DTH induction, and furthermore the same epitope might result in the cross-reactivity between serotypes 3 and 6. The possible importance of these data is discussed in relation to human gene therapy through the application of Ad vectors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15799763     DOI: 10.1111/j.1600-0463.2005.apm1130307.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  2 in total

1.  Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination.

Authors:  Nelson DiPaolo; Shaoheng Ni; Anuj Gaggar; Robert Strauss; Sebastian Tuve; Zong Yi Li; Daniel Stone; Dmitry Shayakhmetov; Nancy Kiviat; Papa Touré; Salif Sow; Branka Horvat; André Lieber
Journal:  Mol Ther       Date:  2006-02-07       Impact factor: 11.454

2.  Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses.

Authors:  A Sharma; M Tandon; Y S Ahi; D S Bangari; R Vemulapalli; S K Mittal
Journal:  Gene Ther       Date:  2010-02-18       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.